B-type natriuretic peptide and cyclic guanosine monophosphate levels increase whereas nitric oxide bioavailability decreases with increasing degree of myxomatous mitral valve disease

Sophia Gry Moesgaard; Bo Torkel Falk; T. Teerlink; Halldóra Hrund Guðmundsdóttir; Sif Sigurðardóttir; Caroline Elisabeth Rasmussen; Lisbeth Høier Olsen

B-type natriuretic peptide and cyclic guanosine monophosphate levels increase whereas nitric oxide bioavailability decreases with increasing degree of myxomatous mitral valve disease

Sophia Gry Moesgaard, Bo Torkel Falk, T. Teerlink, Halldóra Hrund Guðmundsdóttir, Sif Sigurðardóttir, Caroline Elisabeth Rasmussen, Lisbeth Høier Olsen

Original language	English
Title of host publication	ACVIM FORUM - Canadian Veterinary Medical Association
Number of pages	1
Publication date	2009
Pages	707
Publication status	Published - 2009
Event	Rendezvous with Discovery - Montreal, Canada Duration: 3 Jun 2009 → 6 Jun 2009

Conference

Conference	Rendezvous with Discovery
Country/Territory	Canada
City	Montreal
Period	03/06/2009 → 06/06/2009

Access to Document

B-type natriuretic peptide and cyclic guanosine monophosphate levels increase whereas nitric oxide bioavailability decreases with increasing degree of myxomatous mitral valve diseaseFinal published version, 1.4 MB

Cite this

Moesgaard, S. G., Falk, B. T., Teerlink, T., Guðmundsdóttir, H. H., Sigurðardóttir, S., Rasmussen, C. E., & Olsen, L. H. (2009). B-type natriuretic peptide and cyclic guanosine monophosphate levels increase whereas nitric oxide bioavailability decreases with increasing degree of myxomatous mitral valve disease. In ACVIM FORUM - Canadian Veterinary Medical Association (pp. 707)

B-type natriuretic peptide and cyclic guanosine monophosphate levels increase whereas nitric oxide bioavailability decreases with increasing degree of myxomatous mitral valve disease. / Moesgaard, Sophia Gry; Falk, Bo Torkel; Teerlink, T. et al.
ACVIM FORUM - Canadian Veterinary Medical Association. 2009. p. 707.

Research output: Chapter in Book/Report/Conference proceeding › Conference abstract in proceedings › Research

Moesgaard, SG, Falk, BT, Teerlink, T, Guðmundsdóttir, HH, Sigurðardóttir, S, Rasmussen, CE & Olsen, LH 2009, B-type natriuretic peptide and cyclic guanosine monophosphate levels increase whereas nitric oxide bioavailability decreases with increasing degree of myxomatous mitral valve disease. in ACVIM FORUM - Canadian Veterinary Medical Association. pp. 707, Rendezvous with Discovery, Montreal, Canada, 03/06/2009.

@inbook{74ba9e00163111df803f000ea68e967b,

title = "B-type natriuretic peptide and cyclic guanosine monophosphate levels increase whereas nitric oxide bioavailability decreases with increasing degree of myxomatous mitral valve disease",

author = "Moesgaard, {Sophia Gry} and Falk, {Bo Torkel} and T. Teerlink and Gu{\dh}mundsd{\'o}ttir, {Halld{\'o}ra Hrund} and Sif Sigur{\dh}ard{\'o}ttir and Rasmussen, {Caroline Elisabeth} and Olsen, {Lisbeth H{\o}ier}",

year = "2009",

language = "English",

pages = "707",

booktitle = "ACVIM FORUM - Canadian Veterinary Medical Association",

note = "Rendezvous with Discovery ; Conference date: 03-06-2009 Through 06-06-2009",

}

TY - ABST

T1 - B-type natriuretic peptide and cyclic guanosine monophosphate levels increase whereas nitric oxide bioavailability decreases with increasing degree of myxomatous mitral valve disease

AU - Moesgaard, Sophia Gry

AU - Falk, Bo Torkel

AU - Teerlink, T.

AU - Guðmundsdóttir, Halldóra Hrund

AU - Sigurðardóttir, Sif

AU - Rasmussen, Caroline Elisabeth

AU - Olsen, Lisbeth Høier

PY - 2009

Y1 - 2009

M3 - Conference abstract in proceedings

SP - 707

BT - ACVIM FORUM - Canadian Veterinary Medical Association

T2 - Rendezvous with Discovery

Y2 - 3 June 2009 through 6 June 2009

ER -